Cogent Biosciences financial statements

코젠트 바이오사이언시스NASDAQ:COGT · Nasdaq · Healthcare · sector #13
$30.87-0.48%
2026-10-05 close

Cogent Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$276M.

Reported results

Cogent Biosciences notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q